<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"
        xmlns:image="http://www.google.com/schemas/sitemap-image/1.1">
  <url>
    <loc>https://www.pharmanow.live/latest-news/pharming-group-fda-approval-leniolisib-children-apds</loc>
    <lastmod>2026-09-11T23:18:25+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-11T00:00:00+05:30</news:publication_date>
      <news:title>Pharming Group Gains FDA Approval for Leniolisib in Children Aged 4–11 with APDS</news:title>
      <news:keywords>FDA</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/b91f9aa2-bd38-4dcf-9820-dc161878f47f/4d47a470-5afa-4749-aa25-0a836098ae0e.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/lonza-commercial-spray-drying-facility-oregon-sdd-manufacturing</loc>
    <lastmod>2026-09-11T13:51:30+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-11T00:00:00+05:30</news:publication_date>
      <news:title>Lonza Builds Oregon Spray-Drying Facility To Expand SDD Capacity</news:title>
      <news:keywords>Lonza</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/b2eccf0e-ce5f-4e49-8a3b-82df5afa3f1e/bc6bbde4-0588-43e3-905b-add9fe7eb8b0.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/nicox-nmpa-acceptance-ncx-470-nda-china-review</loc>
    <lastmod>2026-09-11T13:47:12+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-11T00:00:00+05:30</news:publication_date>
      <news:title>China NMPA Accepts Nicox NCX 470 NDA; Decision In 18 Months</news:title>
      <news:keywords>China NMPA</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/b2eccf0e-ce5f-4e49-8a3b-82df5afa3f1e/01044b9a-35e6-4a3e-a60d-447e1513c34c.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/axcelead-hitaka-glp-1-rodent-nausea-model-jsso-jsto-2026</loc>
    <lastmod>2026-09-11T10:37:33+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-11T00:00:00+05:30</news:publication_date>
      <news:title>Hitaka To Present Axcelead GLP-1 Rodent Nausea Data At Obesity 26</news:title>
      <news:keywords>Hitaka</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/https://axcelead-us.com/wp-content/uploads/2025/04/hitaka.jpg</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/xortx-initiates-gmp-manufacturing-xorlo-clinical-nda-dossier</loc>
    <lastmod>2026-09-11T13:44:14+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-11T00:00:00+05:30</news:publication_date>
      <news:title>XORTX Initiates GMP Manufacturing Of XORLO™ For Dual Dossier</news:title>
      <news:keywords>XORTX</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/xortx-initiates-gmp-manufacturing-xorlo-clinical20260911134359.webp</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/fda-nih-cdc-workshop-valley-fever-vaccine-regulatory-pathway-2024</loc>
    <lastmod>2026-09-11T13:39:43+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-11T00:00:00+05:30</news:publication_date>
      <news:title>FDA, NIH &amp; CDC Host Workshop On Valley Fever Vaccine Pathway</news:title>
      <news:keywords>FDA</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/fda-nih-cdc-workshop-valley-fever-vaccine-pathway20260911133930.webp</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/medical-action-industries-class-i-correction-epidural-kits-huons-sterility-cascade</loc>
    <lastmod>2026-09-11T10:37:39+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-11T00:00:00+05:30</news:publication_date>
      <news:title>Medical Action Recalls Epidural Kits Over Sterility Risk</news:title>
      <news:keywords>Medical Action</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/a72bc3d0-b709-497c-98a4-e494e7607feb/53139a57-2b33-4fb4-8ce6-45e5bb581c50.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/roche-fda-approval-cobas-malaria-nat-donor-screening</loc>
    <lastmod>2026-09-11T13:25:42+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-11T00:00:00+05:30</news:publication_date>
      <news:title>Roche Cobas Malaria Test Gets FDA Approval For Donor Screening</news:title>
      <news:keywords>Roche</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/roche-fda-approval-cobas-malaria-nat-screening20260911132537.webp</image:loc>
    </image:image>
  </url>
</urlset>